Roy van der Meel is Assistant Professor of Precision Medicine at the TU/e's Biomedical Engineering department. His research is focused on developing RNA-based nanotherapeutics to regulate the immune response in a highly precise manner.
Roy van der Meel studied Biomedical Sciences and Drug Innovation at Utrecht University in The Netherlands where he obtained his M.Sc. degree in 2009. He then conducted his Ph.D. research at the Utrecht University Pharmaceutics Department under supervision of Wim Hennink, Gert Storm, Robbert Jan Kok and Raymond Schiffelers. Roy's research focused on developing nanomedicines to inhibit tumor growth and angiogenesis and he obtained his Ph.D. degree in 2013. After obtaining Marie Skłodowska-Curie Action funding from the European Commission and a Veni grant from the Netherlands Organization for Scientific Research, Roy conducted postdoctoral research in the labs of Raymond Schiffelers (University Medical Center Utrecht) and Pieter Cullis (University of British Columbia, Vancouver, BC, Canada). In 2019, Roy was appointed Assistant Professor of Precision Medicine at the TU/e's Biomedical Engineering department.
Fusion-dependent formation of lipid nanoparticles containing macromolecular payloadsNanoscale (2019)
Translating nanomedicines: Thinking beyond materials?Journal of Controlled Release (2018)
Lipid nanoparticles enabling gene therapiesNucleic Acid Therapeutics (2018)
On the formation and morphology of lipid nanoparticles containing Ionizable cationic lipids and siRNAACS Nano (2018)
State‐of‐the‐art design and rapid‐mixing production techniques of lipid nanoparticles for nucleic acid deliverySmall Methods (2018)
- DBL Entering the lab
No ancillary activities